Nova Eye Medical is looking to raise $8 million to expand its glaucoma surgical device business.
The initiative includes a $3 million placement and a $5 million pro-rata accelerated non-renounceable entitlement offer to support near-term growth opportunities.
The funds will be allocated to enhance iTrackTM Advance in the US and European markets, broaden the glaucoma surgical devices product line, and boost US sales through expanded networks and marketing efforts.
Additional investment is planned for international market access and product portfolio expansion.